These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 562930)

  • 21. [Treatment of osteogenesis imperfecta with calcitonin].
    Iester A; Marchesi A; Fásce L
    Minerva Pediatr; 1979 Mar; 31(6):443-500. PubMed ID: 470887
    [No Abstract]   [Full Text] [Related]  

  • 22. Pyrophosphate levels and magnesium oxide therapy in osteogenesis imperfecta.
    Granda JL; Falvo KA; Bullough PG
    Clin Orthop Relat Res; 1977; (126):228-31. PubMed ID: 202425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of clinical hypomagnesemia. Hypokalemia, hypophosphatemia, hyponatremia, and hypocalcemia.
    Whang R; Oei TO; Aikawa JK; Watanabe A; Vannatta J; Fryer A; Markanich M
    Arch Intern Med; 1984 Sep; 144(9):1794-6. PubMed ID: 6476998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Sodium fluoride therapy of osteogenesis imperfecta in childhood].
    Laszlo A; Sugar E
    Kinderarztl Prax; 1982 Aug; 50(8):416-22. PubMed ID: 7143914
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of osteogenesis imperfecta with calcitonin].
    Socha J; Brzozowska-Wolnik D; Ignyś I; Stańska M
    Pediatr Pol; 1982; 57(9):735-7. PubMed ID: 6763191
    [No Abstract]   [Full Text] [Related]  

  • 26. Osteogenesis imperfecta: anthropometric, skeletal and mineral metabolic effects of long-term intravenous pamidronate therapy.
    Vallo A; Rodriguez-Leyva F; Rodríguez Soriano J
    Acta Paediatr; 2006 Mar; 95(3):332-9. PubMed ID: 16497645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased inorganic serum pyrophosphate in serum and urine of patients with osteogenesis imperfecta.
    Armstrong D; VanWormer D; Solomons CC
    Clin Chem; 1975 Jan; 21(1):104-8. PubMed ID: 163711
    [No Abstract]   [Full Text] [Related]  

  • 28. [Alkaline phosphatase and its isoenzyme activity of the blood in osteogenesis imperfecta before and during treatment with calcitonin].
    Bodziony J; Lukas W; Stanosek J; Ziarek S
    Padiatr Grenzgeb; 1988; 27(4):259-67. PubMed ID: 3174140
    [No Abstract]   [Full Text] [Related]  

  • 29. [Osteogenesis imperfecta. Presentation of 5 cases. Nosographical classification and therapeutic prospects].
    Bianchi C; Carcano G
    Minerva Pediatr; 1978 Nov; 30(21):1689-96. PubMed ID: 723815
    [No Abstract]   [Full Text] [Related]  

  • 30. Calcitonin as a drug.
    Deftos LJ; First BP
    Ann Intern Med; 1981 Aug; 95(2):192-7. PubMed ID: 7258871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Osteogenesis imperfecta. Review of therapeutic methods].
    Lukas W; Bodziony J; Rajpert E
    Pol Tyg Lek; 1981 Jun; 36(22):819-20. PubMed ID: 6269102
    [No Abstract]   [Full Text] [Related]  

  • 32. [Osteogenesis imperfecta. Classification with new aspects for pathogenesis and therapy (author's transl)].
    Harnisch R; Teller WM
    Monatsschr Kinderheilkd (1902); 1978 Oct; 126(10):597-606. PubMed ID: 360052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypertrophic callus formation leading to high-output cardiac failure in a patient with osteogenesis imperfecta.
    Burke TE; Crerand SJ; Dowling F
    J Pediatr Orthop; 1988; 8(5):605-8. PubMed ID: 3170743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitamin D and related research in osteogenesis imperfecta.
    Sbyrakis S; Mengreli C; Côté GB; Morakis A
    Prog Clin Biol Res; 1982; 104():367-76. PubMed ID: 6298814
    [No Abstract]   [Full Text] [Related]  

  • 35. [Therapeutic measures in osteogenesis imperfecta (author's transl)].
    Münzenberg KJ
    Arch Orthop Unfallchir; 1977 Dec; 90(3):265-74. PubMed ID: 607919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Osteogenesis imperfecta: effect of magnesium administration on pyrophosphate metabolism.
    Solomons CC; Styner J
    Calcif Tissue Res; 1969; 3(4):318-26. PubMed ID: 4310540
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of synthetic human, porcine, and salmon calcitonin on calcium and phosphorus in immobilized children.
    Illig R; Budliger H; Kind HP; Fanconi A; Prader A
    Helv Paediatr Acta; 1972 Jun; 27(2):225-38. PubMed ID: 4630190
    [No Abstract]   [Full Text] [Related]  

  • 38. Systemic treatment of osteogenesis imperfecta.
    Albright JA
    Clin Orthop Relat Res; 1981 Sep; (159):88-96. PubMed ID: 7285474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum calcitonin and bone mineral content in patients with osteogenesis imperfecta.
    Nielsen HE; Pedersen U; Hansen HH; Elbrønd O
    Acta Orthop Scand; 1979 Dec; 50(6 Pt 1):639-43. PubMed ID: 532592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medical management of osteogenesis imperfecta [proceedings].
    Paterson CR
    Scott Med J; 1977 Jan; 22(1):87-8. PubMed ID: 836580
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.